Regeneron and Teva Provide Update on Fasinumab Clinical Development Programs

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. ACN
2. SPCX
3. ABBV
4. DFTX
5. APGE
6. MU
7. GXO
8. NCNO
9. NAVN
10. FRVO

Go back to Regeneron and Teva Provide Update on Fasinumab Clinical Development Programs
Mitsubishi Chemical Holdings Corp Unsponsored ADR (AMEX: MTLHY) Delayed: 34.70 --0 (-0%)
Previous Close $34.70    52 Week High $34.07 
Open $34.70    52 Week Low $21.84 
Day High $34.70    P/E N/A 
Day Low $34.70    EPS $0.00 
Volume 2       

Regeneron (NASDAQ: REGN) Delayed: 609.94 --0 (-0%)
Previous Close $609.94    52 Week High $592.36 
Open $609.94    52 Week Low $325.35 
Day High $609.94    P/E 160.09 
Day Low $609.94    EPS $3.81 
Volume 1,315       

TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 31.48 --0 (-0%)
Previous Close $31.48    52 Week High $66.55 
Open $31.48    52 Week Low $37.82 
Day High $31.48    P/E N/A 
Day Low $31.48    EPS $0.00 
Volume 11,660       

TEVA PHARMACEUTICAL INDUSTRIES (NYSE: TEVA) Delayed: 31.48 --0 (-0%)
Previous Close $31.48    52 Week High $66.55 
Open $31.48    52 Week Low $37.82 
Day High $31.48    P/E N/A 
Day Low $31.48    EPS $0.00 
Volume 11,660